Several reports describe a new research direction aimed at protecting the brain in Alzheimer’s disease by targeting the liver. The articles note that currently available Alzheimer’s treatments can slow cognitive and functional decline but are not able to stop or reverse the disease, and some existing medications are associated with side effects. Reported adverse effects include nausea and dizziness, and in some cases more serious outcomes such as brain swelling or bleeding. In contrast, the liver-focused therapy is presented as a potential strategy that could help guard against further brain damage, though the coverage does not provide details about trial stages, specific compounds, or demonstrated effectiveness. The overall theme across the sources is that unmet needs remain in Alzheimer’s treatment, including therapies that could do more than slow progression, and that alternative pathways—such as liver-related mechanisms—are being explored. The reports emphasize the limitations of current drug options and the need for approaches that may reduce harms while better addressing disease biology.
Liver-targeted therapy proposed as potential approach to protect against Alzheimer’s brain decline
Several reports describe a new research direction aimed at protecting the brain in Alzheimer’s disease by targeting the liver. The articles note that currently available Alzheimer’s treatments can slo...
- Current Alzheimer’s drugs can slow decline but cannot stop or reverse the disease.
- Some Alzheimer’s treatments are associated with side effects including nausea and dizziness.
- Some treatments have been linked to serious complications such as brain swelling or bleeding.
- A proposed new therapy targets the liver with the aim of protecting the brain.
- The reports frame liver-targeted protection as a potential alternative research direction for Alzheimer’s.
Current drugs can slow the decline but cannot stop or reverse it, and many carry troubling side-effects such as nausea, dizziness and, in some cases, brain swelling or bleeding.
2 months agoCurrent drugs can slow the decline but cannot stop or reverse it, and many carry troubling side-effects such as nausea, dizziness and, in some cases, brain swelling or bleeding.
2 months ago
French court recognizes cosmic radiation as factor in Air France flight attendant’s breast cancer
A French court in Bayonne recognizes that cosmic radiation contributed to the breast cancer of former Air France steward...
Federal judge overturns Texas ban on drag shows, citing First Amendment concerns and Dolly Parton
A federal judge strikes down a Texas law that sought to restrict drag shows, saying it violates the First Amendment. The...
FDA approves new pancreatic cancer drug shown to improve survival
The U.S. Food and Drug Administration approves a new drug for pancreatic cancer that studies show can improve survival f...